Oral GLP-1 therapies activate GLP-1 receptors to boost insulin secretion, slow gastric emptying, and reduce appetite, leading to weight loss and improved glucose control
VA to run trial of GLP-1 drug to treat alcohol abuse The Department of Veterans Affairs on Thursday announced a clinical trial to test whether injectable semaglutide, a GLP-1 drug widely prescribed for diabetes and weight loss can also treat alcohol abuse, a longstanding problem in the military and veteran community
u003ca href=u0022#medical-conditions-that-qualify-for-hsa-fsa-use-with-a-glp-1u0022u003eFSA funds can be used for weight-loss programsu003c/au003e only when weight loss is prescribed to treat a diagnosed medical condition, not cosmetic goals
Trulicity offers FDA-approved cardiovascular risk reduction and is approved for pediatric patients aged 10 and older
If the prescription is written for more frequent dosing, additional justification is required
And at the highest level, they get categorized as either being fat-soluble or water-soluble
